Mallinckrodt's pulse oximetry technology:
This article was originally published in Clinica
Mallinckrodt has received US 510(k) clearance for its next-generation pulse oximetry technology, Nellcor Oxismart advanced digital signal processing and SatSeconds alarm management. While the Oxismart software is able to detect and track pulse rate and oxygen saturation levels during motion, the alarm management technology reduces the number of false alarms by over 90%, said the Pleasanton, California-based company.
You may also be interested in...
With its US/Mexico Phase III trial delayed due to manufacturing questions, Novavax has aligned its UK study with FDA guidance. It hopes for interim data from that study during Q1 2021.
The companies think they can build out the indications for zuranalone and SAGE-324 faster and more broadly and commercialize the drugs more effectively as partners.